BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liao W, Lim AYH, Tan WSD, Abisheganaden J, Wong WSF. Restoration of HDAC2 and Nrf2 by andrographolide overcomes corticosteroid resistance in chronic obstructive pulmonary disease. Br J Pharmacol 2020;177:3662-73. [PMID: 32335896 DOI: 10.1111/bph.15080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Audousset C, McGovern T, Martin JG. Role of Nrf2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches - Pulmonary Disease/Asthma. Front Physiol 2021;12:727806. [PMID: 34658913 DOI: 10.3389/fphys.2021.727806] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rodrigues SO, Cunha CMCD, Soares GMV, Silva PL, Silva AR, Gonçalves-de-Albuquerque CF. Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease. Pharmaceuticals (Basel) 2021;14:979. [PMID: 34681202 DOI: 10.3390/ph14100979] [Reference Citation Analysis]
3 Geronikolou SA, Pavlopoulou A, Chrousos GP, Cokkinos DV. Interactions Networks for Primary Heart Sarcomas. Cancers (Basel) 2021;13:3882. [PMID: 34359782 DOI: 10.3390/cancers13153882] [Reference Citation Analysis]
4 Shi TH, Huang YL, Chen CC, Pi WC, Hsu YL, Lo LC, Chen WY, Fu SL, Lin CH. Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage. Biochem Biophys Res Commun 2020;533:467-73. [PMID: 32977949 DOI: 10.1016/j.bbrc.2020.08.086] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
5 Zhang H, Li S, Si Y, Xu H. Andrographolide and its derivatives: Current achievements and future perspectives. Eur J Med Chem 2021;224:113710. [PMID: 34315039 DOI: 10.1016/j.ejmech.2021.113710] [Reference Citation Analysis]
6 Dai L, Xu D, Wan C, Liu L, Wen F. DKK1 Positively Correlates with Lung Function in COPD Patients and Reduces Airway Inflammation. Int J Chron Obstruct Pulmon Dis 2022;17:93-100. [PMID: 35027825 DOI: 10.2147/COPD.S341249] [Reference Citation Analysis]
7 Qu J, Liu Q, You G, Ye L, Jin Y, Kong L, Guo W, Xu Q, Sun Y. Advances in ameliorating inflammatory diseases and cancers by andrographolide: Pharmacokinetics, pharmacodynamics, and perspective. Med Res Rev 2021. [PMID: 34877672 DOI: 10.1002/med.21873] [Reference Citation Analysis]
8 Liao W, Lim AYH, Tan WSD, Abisheganaden J, Wong WSF. Restoration of HDAC2 and Nrf2 by andrographolide overcomes corticosteroid resistance in chronic obstructive pulmonary disease. Br J Pharmacol 2020;177:3662-73. [PMID: 32335896 DOI: 10.1111/bph.15080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
9 Pei G, Ma N, Chen F, Guo L, Bai J, Deng J, He Z. Screening and Identification of Hub Genes in the Corticosteroid Resistance Network in Human Airway Epithelial Cells via Microarray Analysis. Front Pharmacol 2021;12:672065. [PMID: 34707493 DOI: 10.3389/fphar.2021.672065] [Reference Citation Analysis]
10 Lewis BW, Ford ML, Rogers LK, Britt RD Jr. Oxidative Stress Promotes Corticosteroid Insensitivity in Asthma and COPD. Antioxidants (Basel) 2021;10:1335. [PMID: 34572965 DOI: 10.3390/antiox10091335] [Reference Citation Analysis]
11 Xu Y, Liu H, Song L. Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review. J Nanobiotechnology 2020;18:145. [PMID: 33076918 DOI: 10.1186/s12951-020-00703-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]